Inventors and founders of Lytix Biopharma in NRK’s Schrödingers Katt. Watch the programme in Norwegian.

Leaders in synthetic micropeptides

Lytix Biopharma AS is a privately-owned pharmaceutical company focussed on anti-microbials and cancer therapeutics.

The Company develops novel drugs for the treatment of resistant bacterial and fungal infections, as well as first-in-class oncology treatments.

Selective, ultra-rapid membrane disruption

Time 0 min                5 min                  10 min                  20 min




Tromsø, Norway, and Seoul, Korea, June 18, 2009:
- Lytix Biopharma and KAEL–GemVax announce joint clinical trial
June 02, 2009:
- North Murray AS has exercised warrant.
March 24, 2009:
- Lytix Biopharma has issued shares and a warrant directed at North Murray AS / Gert W. Munthe
February 26, 2009:
- 8 new job openings. We will expand our team of drug development professionals in support of the ...